Future study designs evaluating cognitive dysfunction in patients on aromatase inhibitors should include a multifaceted approach of neuropsychiatric testing and neurological functional imaging.

Table 1. Summary of medical therapy (chemotherapy and aromatase inhibitors) and measurements of cognitive functioning (neuropsychological testing and functional imaging) and potential confounders ...

Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the RANK ligand inhibitor can be challenging to navigate. "I don't think we ...

In 2004, the American Society of Clinical Oncology reported its evaluation of the use of aromatase inhibitors (AIs) in the adjuvant treatment of postmenopausal breast cancer. While the panel endorsed ...

One study found that taking an estrogen blocker called an aromatase inhibitor while on testosterone therapy reduced estrogen and addressed low testosterone levels.

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.